Esperto Medical

Executive Summary

Esperto Medical is a San Francisco-based digital health startup founded in 2021 that aims to revolutionize non-invasive diagnostic technologies, particularly for vital sign monitoring. By leveraging AI and machine learning, the company seeks to replace outdated monitoring systems with advanced, non-invasive solutions that improve clinician efficiency and patient access. The company's core mission is to free healthcare providers from the burden of traditional vital sign monitoring, enabling more focus on patient care. With a strong emphasis on innovation and accessibility, Esperto Medical is poised to address a critical bottleneck in healthcare delivery. Although still in early stages (stage classified as 'Approved'), the startup has not publicly disclosed funding or valuation. Its technology targets a large market opportunity in hospital and remote patient monitoring, where non-invasive, AI-driven diagnostics are gaining traction. If successful, Esperto Medical could significantly reduce the cost and complexity of continuous monitoring, potentially transforming standard care practices. The company's approach aligns with broader industry trends toward digital health and decentralized care, positioning it for growth pending regulatory and commercial milestones.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Submission for Non-Invasive Vital Signs Monitor60% success
• Q4 2026Strategic Partnership with a Major Hospital Network70% success
• Q2 2026Completion of Series A Funding Round80% success